Evidence map›Paper›PMID 28431981›Full record

ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2017

Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation.

Sarah B See, Kevin J Clerkin, Peter J Kennel, Feifan Zhang, Matthew P Weber, Kortney J Rogers, Debanjana Chatterjee, Elena R Vasilescu, George Vlad, Yoshifumi Naka and 8 more

Abstract readMulticenter Study
In one paragraph

Article in The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Profiling non-HLA antibody responses in antibody-mediated rejection following heart transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sarah B SeeColumbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.
Kevin J ClerkinDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York.
Peter J KennelColumbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.
Feifan ZhangDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York.
Matthew P WeberDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York.
Kortney J RogersColumbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.
Debanjana ChatterjeeColumbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.
Elena R VasilescuDepartment of Pathology and Cell Biology, Department of Surgery, Columbia University Medical Center, New York, New York.
George VladDepartment of Pathology and Cell Biology, Department of Surgery, Columbia University Medical Center, New York, New York.
Yoshifumi NakaDivision of Cardiothoracic Surgery, Department of Surgery, Columbia University Medical Center, New York, New York.
Susan W RestainoDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York.
Maryjane A FarrDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York.
Veli K TopkaraDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York.
Paolo C ColomboDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York.
Donna M ManciniDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York.
P Christian SchulzeDivision of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York.
Bruce LevinDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York.
Emmanuel ZornColumbia Center for Translational Immunology, Columbia University Medical Center, New York, New York. Electronic address: ez2184@cumc.columbia.edu.

Funding

POSTDOCTORAL TRAINING IN CARDIOVASCULAR DISEASET32HL007854 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Marwah Abdalla, Michael Argenziano · 1996 to 2026
$14.7M
Contribution of B cells to human cardiac allograft vasculopathyR01AI116814 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZORN, EMMANUEL · 2015 to 2019
$1.8M
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
NCRR NIH HHS S10 RR027050NHLBI NIH HHS T32 HL007854NIAID NIH HHS R01 AI116814
6 · The paper itself

Abstract

backgroundPre-transplant sensitization is a limiting factor in solid-organ transplantation. In heart transplants, ventricular assist device (VAD) implantation has been associated with sensitization to human leukocyte antigens (HLA). The effect of VAD on non-HLA antibodies is unclear. We have previously shown that polyreactive natural antibodies (Nabs) contribute to pre-sensitization in kidney allograft recipients. Here we assessed generation of Nabs after VAD implantation in pre-transplant sera and examined their contribution to cardiac allograft outcome.

methodsIgM and IgG Nabs were tested in pre-transplant serum samples collected from 206 orthotopic heart transplant recipients, including 128 patients with VAD (VAD patients) and 78 patients without VAD (no-VAD patients). Nabs were assessed by testing serum reactivity to apoptotic cells by flow cytometry and to the generic oxidized epitope, malondialdehyde, by enzyme-linked immunosorbent assay.

resultsNo difference was observed in serum levels of IgM Nabs between VAD and no-VAD patients. However, serum IgG Nabs levels were significantly increased in VAD compared with no-VAD patients. This increase was likely due to the presence of the VAD, as revealed by lower serum IgG Nabs levels before implantation. Elevated pre-transplant IgG Nabs level was associated with development of primary graft dysfunction (PGD).

conclusionsOur study demonstrates that VAD support elicits IgG Nabs reactive to apoptotic cells and oxidized epitopes. These findings further support broad and non-specific B-cell activation by VAD, resulting in IgG sensitization. Moreover, the association of serum IgG Nabs levels with development of PGD suggests a possible role for these antibodies in the inflammatory reaction accompanying this complication.

Indexed as

AllograftsAngiographyAntibodies, Anti-IdiotypicApoptosisBiomarkersB-LymphocytesEnzyme-Linked Immunosorbent AssayEpitopesFemaleFlow CytometryHeart-Assist DevicesHeart FailureHeart TransplantationHumansImmunoglobulin GMaleAntibodies, Anti-IdiotypicBiomarkersEpitopesImmunoglobulin GB1 cellsnatural polyreactive antibodiesnon-HLA antibodiesorthotopic heart transplantprimary graft dysfunctionsensitizationventricular assist device

Identifiers

PMID28431981
PMCPMC5515682

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.